Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1

Read full text Summarise with VIRAT
Authors: Yuya Sugitatsu, Akimasa Tomida, Masaya Suematsu, Tomoya Inoue, Hiroshi Kubo, Yozo Nakazawa, Shigeki Yagyu, Tomoko Iehara
Cited by: 0
References: 37

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Neuroblastoma Research and Treatments CAR-T cell therapy research Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
British Journal of Cancer
Volume
134
Issue
10
Pages
1488–1496
Publication date
23 March 2026
Language
EN